SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-763698
Filing Date
2016-11-09
Accepted
2016-11-09 07:18:58
Documents
58
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d268086d10q.htm 10-Q 417493
2 EX-10.1 d268086dex101.htm EX-10.1 63501
3 EX-31.1 d268086dex311.htm EX-31.1 8883
4 EX-31.2 d268086dex312.htm EX-31.2 8889
5 EX-32.1 d268086dex321.htm EX-32.1 3489
6 EX-32.2 d268086dex322.htm EX-32.2 3500
  Complete submission text file 0001193125-16-763698.txt   3441591

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT kerx-20160930.xml EX-101.INS 585172
8 XBRL TAXONOMY EXTENSION SCHEMA kerx-20160930.xsd EX-101.SCH 37459
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kerx-20160930_cal.xml EX-101.CAL 58091
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kerx-20160930_def.xml EX-101.DEF 248205
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE kerx-20160930_lab.xml EX-101.LAB 344700
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kerx-20160930_pre.xml EX-101.PRE 289545
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30929 | Film No.: 161982782
SIC: 2834 Pharmaceutical Preparations